We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Tevimbra
Australian Public Assessment Report
Device/Product Name
Tevimbra
Active ingredients
Tislelizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-02507-1-4
Submission Type
New chemical entity
Decision
Approved